FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ranitidine (Zantac) Tablets
Status: Discontinuation
»Therapeutic Categories: Gastroenterology

Expand all

GlaxoSmithKline (New 09/01/2017)

Company Contact Information:
908-293-5330

Presentation Posting Date Related Information
150 mg tablets; 60-count bottles (NDC 0173-0344-42) 09/01/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy.
300 mg tablets; 30-count bottles (NDC 0173-0393-40) 09/01/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy. The anticipated final date of availability to patients is July 31, 2018.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English